Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: MRKR) | Delayed: 0.98 -0.09 (8.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.07 | 52 Week High | $ | |||
| Open | $1.07 | 52 Week Low | $ | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $0.97 | EPS | $ | |||
| Volume | 95,975 | |||||
